Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Rook

Showing results (11-20 of 187) with videos related to

Pageof 19
Sort By:
The Journal of Investigative Dermatology|March 1, 1991
Molecular diagnosis of cutaneous T-cell lymphoma: polymerase chain reaction amplification of T-cell antigen receptor beta-chain gene rearrangementsS R Lessin, A H Rook, G Rovera
Dermatologic Clinics|April 1, 1994
Retroviruses and cutaneous T-cell lymphomaS R Lessin, B R Vowels, A H Rook
Advances in Experimental Medicine and Biology|February 9, 2021
Interleukin-31, a Potent Pruritus-Inducing Cytokine and Its Role in Inflammatory Disease and in the Tumor MicroenvironmentAlain H Rook, Kathryn A Rook, Daniel J Lewis
Hematology/Oncology Clinics of North America|January 9, 2004
Cytokine therapy of cutaneous T-cell lymphoma: interferons, interleukin-12, and interleukin-2Alain H Rook, Timothy M Kuzel, Elise A Olsen
Transplantation|October 1, 1984
Decreased circulating large granular lymphocytes associated with depressed natural killer cell activity in renal transplant recipientsK M Ramsey, J Y Djeu, A H Rook
Archives of Dermatology|November 1, 1993
Molecular diagnosis of lymphocytic infiltrates of the skinJ M Weinberg, A H Rook, S R Lessin
The Journal of Investigative Dermatology|August 12, 1998
Photoactivated hypericin is an anti-proliferative agent that induces a high rate of apoptotic death of normal, transformed, and malignant T lymphocytes: implications for the treatment of cutaneous lymphoproliferative and inflammatory disordersF E Fox, Z Niu, A Tobia, et al.
The Journal of Allergy and Clinical Immunology|July 1, 1995
Expression of interleukin-4 and interleukin-5 mRNA in developing cutaneous late-phase reactionsB R Vowels, A H Rook, M Cassin, et al.
Journal of the American Academy of Dermatology|December 22, 2020
The immunopathogenesis and immunotherapy of cutaneous T cell lymphoma: Pathways and targets for immune restoration and tumor eradicationJoseph S Durgin, David M Weiner, Maria Wysocka, et al.
Journal of the American Academy of Dermatology|July 21, 2001
Complete molecular remission during biologic response modifier therapy for Sézary syndrome is associated with enhanced helper T type 1 cytokine production and natural killer cell activityE K Yoo, M Cassin, S R Lessin, et al.
Pageof 19

Showing results (11-20 of 187) with videos related to

Sort By:
Pageof 19
The Journal of Investigative Dermatology|March 1, 1991
Molecular diagnosis of cutaneous T-cell lymphoma: polymerase chain reaction amplification of T-cell antigen receptor beta-chain gene rearrangementsS R Lessin, A H Rook, G Rovera
Dermatologic Clinics|April 1, 1994
Retroviruses and cutaneous T-cell lymphomaS R Lessin, B R Vowels, A H Rook
Advances in Experimental Medicine and Biology|February 9, 2021
Interleukin-31, a Potent Pruritus-Inducing Cytokine and Its Role in Inflammatory Disease and in the Tumor MicroenvironmentAlain H Rook, Kathryn A Rook, Daniel J Lewis
Hematology/Oncology Clinics of North America|January 9, 2004
Cytokine therapy of cutaneous T-cell lymphoma: interferons, interleukin-12, and interleukin-2Alain H Rook, Timothy M Kuzel, Elise A Olsen
Transplantation|October 1, 1984
Decreased circulating large granular lymphocytes associated with depressed natural killer cell activity in renal transplant recipientsK M Ramsey, J Y Djeu, A H Rook
Archives of Dermatology|November 1, 1993
Molecular diagnosis of lymphocytic infiltrates of the skinJ M Weinberg, A H Rook, S R Lessin
The Journal of Investigative Dermatology|August 12, 1998
Photoactivated hypericin is an anti-proliferative agent that induces a high rate of apoptotic death of normal, transformed, and malignant T lymphocytes: implications for the treatment of cutaneous lymphoproliferative and inflammatory disordersF E Fox, Z Niu, A Tobia, et al.
The Journal of Allergy and Clinical Immunology|July 1, 1995
Expression of interleukin-4 and interleukin-5 mRNA in developing cutaneous late-phase reactionsB R Vowels, A H Rook, M Cassin, et al.
Journal of the American Academy of Dermatology|December 22, 2020
The immunopathogenesis and immunotherapy of cutaneous T cell lymphoma: Pathways and targets for immune restoration and tumor eradicationJoseph S Durgin, David M Weiner, Maria Wysocka, et al.
Journal of the American Academy of Dermatology|July 21, 2001
Complete molecular remission during biologic response modifier therapy for Sézary syndrome is associated with enhanced helper T type 1 cytokine production and natural killer cell activityE K Yoo, M Cassin, S R Lessin, et al.
Pageof 19